Restogal Pharmaceuticals Private Limited

Restogal Pharmaceuticals Private Limited - chemicals in Gurugram, Haryana, India. FY 2026 financials & compliance.
CIN U24110HR2020PTC088847 Incorporated 31 August 2020 ROC Delhi HQ Gurugram, Haryana, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2024
₹2.16 Lakh
▼ 68% YoY
Net loss · FY 2024
₹2.49 Lakh
Net margin -115.7%
EBITDA · FY 2024
-₹2.35 Lakh
EBITDA margin -109.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Restogal Pharmaceuticals Private Limited

Data last updated:

Restogal Pharmaceuticals Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 31 August 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24110HR2020PTC088847. Its GSTIN is 10AAKCR3957Q1ZT (Bihar).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Bhola Rai and Shilpa Kumari.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O – Nitin Jain Plot No – 190 Sector – 7 Imt – Manesar, Gurugram, Haryana, India – 122052.

As per the financials filed for FY 2024, the company reported a revenue of ₹2.16 Lakh, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹2.49 Lakh (net margin -115.7%) and EBITDA of -₹2.35 Lakh (EBITDA margin -109.1%).

Restogal Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0006278).

Company details

CIN U24110HR2020PTC088847
Registration Number 088847
Incorporation Date 31 August 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-HR-05-0006278

Recognitions & Rankings of Restogal Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2020-21)
Udyam number
UDYAM-HR-05-0006278

Contact details

Restogal Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    C/O – Nitin Jain Plot No – 190 Sector – 7 Imt – Manesar, Gurugram, Haryana, India – 122052
  • Industry
    Chemicals, Manufacturing, Basic Chemical, Basic Chemicals Except Fertilizers And Nitrogen Compounds

To see the full contact details of Restogal Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Restogal Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Restogal Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Restogal Pharmaceuticals Private Limited, buy the company report.

Financials of Restogal Pharmaceuticals Private Limited

FY 2025 filings available

Restogal Pharmaceuticals Private Limited reported revenue of ₹2.16 Lakh (down 68% YoY) for FY 2024.

Revenue · FY 2024
₹2.16 Lakh ▼ 68%
Net loss · FY 2024
₹2.49 Lakh margin -115.7%
EBITDA · FY 2024
-₹2.35 Lakh margin -109.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 68%
EBITDA CAGR growth
1 year
▼ 50%
3 years · compounded
▼ 124%

Revenue fell 68% in the latest year. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.35 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹2.49 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-109.1%
Net Profit Margin-115.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Restogal Pharmaceuticals Private Limited, buy the company report.

Board of directors of Restogal Pharmaceuticals Private Limited

Restogal Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhola RaiDirector31 Aug 20206 Years 2 MonthsCurrent
Shilpa KumariDirector31 Aug 20206 Years 2 MonthsCurrent

Peer comparison

Restogal Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dermatrait Pharmaceuticals Private Limited₹2.17 Lakh (FY 2025)-7.0%Delhi, India
Restogal Pharmaceuticals Private Limitedthis company₹2.16 Lakh (FY 2024)-₹2.49 Lakh-115.7%-68.0%Gurugram, Haryana, India
Tasha Pharmaceuticals Private Limited₹2.12 Lakh (FY 2021)-67.0%Patna, Bihar, India
Medigenium Pharmaceuticals Private Limited₹2.11 Lakh (FY 2025)-88.0%Patna, Bihar, India
Capitis Pharmaceuticals Private Limited₹2.1 Lakh (FY 2022)-39.0%Aurangabad, Maharashtra, India

To see the full peer comparison of Restogal Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Restogal Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Restogal Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
10AAKCR3957Q1ZTBiharActive03 Nov 2020

To see the full GST registrations and return filing status of Restogal Pharmaceuticals Private Limited, buy the company report.

Recent activity

Restogal Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Bhola Rai was appointed as Director on 31 Aug 2020.

AGM
Restogal Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Restogal Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Bhola Rai was appointed as Director.
Appointed
Shilpa Kumari was appointed as Director.
Incorporation
31 Aug 2020
Restogal Pharmaceuticals Private Limited was registered on 31 Aug 2020 with Roc Delhi & aged 6 years 2 months as per MCA records.

Frequently asked questions

Restogal Pharmaceuticals is an active private limited company based in Gurugram, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 31 August 2020 (6+ years old) and is registered under CIN U24110HR2020PTC088847.

Restogal Pharmaceuticals has 2 current directors:

The latest financial statements of Restogal Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The GSTIN of Restogal Pharmaceuticals is 10AAKCR3957Q1ZT, registered in Bihar.

The CIN (Corporate Identification Number) of Restogal Pharmaceuticals is U24110HR2020PTC088847. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Restogal Pharmaceuticals was incorporated on 31 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Restogal Pharmaceuticals by revenue are Dermatrait Pharmaceuticals Private Limited, Tasha Pharmaceuticals Private Limited, Medigenium Pharmaceuticals Private Limited, Capitis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Bhola Rai was appointed as Director on 31 Aug 2020. Shilpa Kumari was appointed as Director on 31 Aug 2020.

Yes, Restogal Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-05-0006278).

The registered office of Restogal Pharmaceuticals is at CO – Nitin Jain Plot No – 190 Sector – 7 Imt – Manesar, Gurugram, Haryana, India – 122052.

Restogal Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.